Phase 3 Neuropathic Pain Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
Neuropathic PainCoccygodyniaCoccyx Disorder
Nantes University Hospital188 enrolled6 locationsNCT06023706
Recruiting
Phase 3
Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children
Chronic PainNeuropathic Pain
University Hospital, Brest46 enrolled10 locationsNCT05997979
Recruiting
Phase 3
Mechanisms of Stimulation for Pain Alleviation
Chronic Neuropathic PainChronic Neuropathic Pain in the Low Back and LegsPeripheral Nerve Stimulation
Stanford University148 enrolled1 locationNCT06741579
Recruiting
Phase 3
Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain
Neuropathic Pain
EMS136 enrolled1 locationNCT04666714
Completed
Phase 2Phase 3
Evaluating two doses of intravenous lidocaine infusion for relief of nerve-related pain that persists after trauma or surgery.
Peripheral neuropathic pain that persists after trauma or surgery.
Royal Brisbane and Women's Hospital40 enrolled1 locationACTRN12622000538741
Not Yet Recruiting
Phase 3
Intermittent infusion of lidocaine, magnesium sulphate and ketamine in the treatment of neuropathic pain, Chronic Regional Pain Syndrome and fibromyalgia. A pilot study.
FibromyalgiaNeuropathic Pain
Daniel Ellyard30 enrolled1 locationACTRN12619000494134
Recruiting
Phase 2Phase 3
The role of vitamin D in the treatment of nerve pain in diabetes
Neuropathic pain in type 2 diabetes
St Vincent's Hospital60 enrolled1 locationACTRN12610000322033